L-DOS47 enhances response to immunotherapy in pancreatic cancer tumor.
Jardim-Perassi BV, Irrera P, Abrahams D, Estrella VC, Ordway B, Byrne SR, Ojeda AA, Whelan CJ, Kim J, Beatty MS, Damgaci-Erturk S, Longo DL, Gaspar KJ, Siegers GM, Centeno BA, Lau JYC, Ibrahim-Hashim A, Pilon-Thomas SA, Gillies RJ.
Jardim-Perassi BV, et al. Among authors: ordway b.
bioRxiv [Preprint]. 2023 Aug 28:2023.08.28.555194. doi: 10.1101/2023.08.28.555194.
bioRxiv. 2023.
PMID: 37693389
Free PMC article.
Updated.
Preprint.